Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells

スポンサーリンク

概要

• 論文の詳細を見る

• Hepatic ATP-binding cassette transporter A1 (ABCA1) plays a key role in high-density lipoprotein (HDL) production by apolipoprotein A-I (ApoA-I) lipidation. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, statins, increase ABCA1 mRNA levels in hepatoma cell lines, but their mechanism of action is not yet clear. We investigated how statins increase ABCA1 in rat hepatoma McARH7777 cells. Pitavastatin, atorvastatin, and simvastatin increased total ABCA1 mRNA levels, whereas pravastatin had no effect. Pitavastatin also increased ABCA1 protein. Hepatic ABCA1 expression in rats is regulated by both liver X receptor (LXR) and sterol regulatory element–binding protein (SREBP2) pathways. Pitavastatin repressed peripheral type ABCA1 mRNA levels and its LXR-driven promoter, but activated the liver-type SREBP-driven promoter, and eventually increased total ABCA1 mRNA expression. Furthermore, pitavastatin increased peroxisome proliferator–activated receptor α (PPARα) and its downstream gene expression. Knockdown of PPARα attenuated the increase in ABCA1 protein, indicating that pitavastatin increased ABCA1 protein via PPARα activation, although it repressed LXR activation. Furthermore, the degradation of ABCA1 protein was retarded in pitavastatin-treated cells. These data suggest that pitavastatin increases ABCA1 protein expression by dual mechanisms: SREBP2-mediated mRNA transcription and PPARα-mediated ABCA1 protein stabilization, but not by the PPAR–LXR–ABCA1 pathway. [Supplementary Figures: available only at http://dx.doi.org/10.1254/jphs.10241FP]

著者

• Nishimaki-mogami Tomoko

  Division Of Medical Chemistry National Institute Of Hygienic Sciences

• Yamazaki Hiroyuki

  Tokyo New Drug Research Laboratories I, Kowa Company, Ltd.

• Maejima Takashi

  Tokyo New Drug Research Laboratories I Pharmaceutical Division Kowa Co. Ltd.

• Sugano Tomohiro

  Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Japan

• Yoshinaka Yasunobu

  Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Japan

• Doi Takeshi

  Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Japan

• Tanabe Sohei

  Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Japan

• Yamazaki Hiroyuki

  Tokyo New Drug Research Laboratories I Kowa Company Ltd

• Doi Takeshi

  Tokyo New Drug Research Laboratories Kowa Company Ltd.

• Yoshinaka Yasunobu

  Tokyo New Drug Research Laboratories Kowa Company Ltd.

• Tanabe Sohei

  Tokyo New Drug Research Laboratories Kowa Company Ltd.

• Maejima Takashi

  Tokyo New Drug Research Laboratories Kowa Company Ltd.

• Sugano Tomohiro

  Tokyo New Drug Research Laboratories Kowa Company Ltd.

関連論文

• PE-044 Novel Regulation Pathway of the LDL Receptor Family for Migration of Vascular Smooth Muscle Cells(Atherosclerosis, basic-3 (H) PE8,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Analysis of the Global RNA Expression Profiles of Skeletal Muscle Cells Treated with Statins
• OE-235 Knockout of LR11 Gene, a Regulator of Migration of Intimal SMCs, Drastically Inhibits Intimal Thickning of Injured Artery in Mice(Atherosclerosis, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-102 LR11, a nobel circulating marker of atherosclerosis is essential for anglotensin II -induced SMC migration(Atherosclerosis, basic(02)(IHD),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• OE-234 A Secreted Soluble Form of LR11, Specifically Expressed in Intimal Smooth Muscle Cells, Accelerates a Formation of Lipid-Accumulated Macrophages(Atherosclerosis, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Effects of Chemical Modification of Ursodeoxycholic Acid on TGR5 Activation
• EFFECTS OF ROSE BENGAL ON SERUM LEVELS OF THYROID HORMONES AND THYROID PEROXIDASE ACTIVITY IN MALE MICE.
• Influence of 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors on Ubiquinone Levels in Rat Skeletal Muscle and Heart : Relationship to Cytotoxicity and Inhibitory Activity for Cholesterol Synthesis in Human Skeletal Muscle Cells
• A Comparison of Differences in the Gene Expression Profiles of Phorbol 12-myristate 13-acetate Differentiated THP-1 Cells and Human Monocyte-derived Macrophage
• The Gene Expression Profile of Human Umbilical Vein Endothelial Cells Stimulated by Tumor Necrosis Factor α Using DNA Microarray Analysis
• A Novel Zinc Finger Protein mRNA in Human Umbilical Vein Endothelial Cells is Profoundly Induced by Tumor Necrosis Factor α
• A Novel Member of the LDL Receptor Gene Family with Eleven Binding Repeats is Structurally Related to Neural Adhesion Molecules and a Yeast Vacuolar Protein Sorting Receptor
• The Generation of Monoclonal Antibodies against Human Peroxisome Proliferator-activated Receptors(PPARs)
• Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells
• Pitavastatin Increases ABCA1 Expression by Dual Mechanisms : SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells

もっと見る 閉じる

スポンサーリンク